Sirrus
Date | Investors | Amount | Round |
---|---|---|---|
$1.1m | Series A | ||
$13.6m | Series A | ||
N/A | N/A | Early VC | |
$14.3m | Series A | ||
N/A | N/A | Early VC | |
$5.0m | Debt | ||
$6.5m | Series B | ||
N/A | N/A | Early VC | |
N/A | Acquisition | ||
Total Funding | AUD54.8m |
Recent News about Sirrus
EditSirrus Chemistry specializes in the development of advanced methylene malonate crosslinkers, which are used to create superior coatings, adhesives, sealants, and encapsulants. The company serves a wide range of industries including automotive, packaging, wood products, construction, medical, and electronics. Sirrus operates in the specialty chemicals market, focusing on enhancing product performance and reducing environmental impact. Their business model involves partnering with formulators and manufacturers to integrate their unique chemical solutions into various products. Revenue is generated through the sale of these specialized chemical compounds and through licensing agreements. Sirrus aims to drive innovation in product formulations, offering benefits such as rapid polymerization at ambient temperatures, reduced energy requirements, and lower solvent usage.
Keywords: methylene malonate, crosslinkers, coatings, adhesives, sealants, automotive, packaging, construction, medical, electronics.